Cognitive Impairment Following Intrathecal Methotrexate for Medulloblastoma

J Gordon Millichap

doi:10.15844/pedneurbriefs-16-7-5

Cognitive Impairment Following Intrathecal Methotrexate for Medulloblastoma

Pediatric Neurology Briefs

Volume 16 (2002): Issue 7

By: J Gordon Millichap

Open Access

|Jul 2002

Abstract

Intelligence, executive function, attention, visual perception, and short-term memory were assessed in two groups of children who underwent surgery and subsequent radiotherapy and chemotherapy for cerebellar medulloblastoma at the Carlo Besta National Neurologic Institute, Milan, Italy.

References

Riva D Giorgi C Nichelli F Bulgheroni S Massimino M Cefalo G Gandola L Intrathecal methotrexate affects cognitive function in children with medulloblastoma Neurology 2002 Jul 9 59 1 48 53 10.1212/wnl.59.1.48 12105306
Open DOI Search in Google Scholar Back to article
Duffner PK Cohen ME The long-term effects of central nervous system therapy on children with brain tumors Neurol Clin 1991 May 9 2 479 95 1944111
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-16-7-5 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 52 - 52

Published on: Jul 1, 2002

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Methotrexate,

Executive Function,

Medulloblastoma

© 2002 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 16 (2002): Issue 7